Patent ID: 11945824
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A compound represented by Formula (I): or a pharmaceutically acceptable salt thereof, wherein:, A is an optionally substituted aryl or optionally substituted heteroaryl;
B is O or S;
R1 and R2 are each independently hydrogen, fluorine, or an optionally substituted C1-C4 alkyl;
R3 is selected from the group consisting of hydrogen, fluorine, hydroxy, and optionally substituted C1-C6 alkoxy;
R4 is selected from the group consisting of hydrogen, optionally substituted C1-C6 alkyl, optionally substituted C2-C6 alkenyl, optionally substituted C2-C6 alkynyl, optionally substituted C3-C6 cycloalkyl, and optionally substituted C3-C6 heterocyclic;
Z is selected from the group consisting of hydrogen, halogen, hydroxy, cyano, optionally substituted C1-C6 alkyl, optionally substituted C3-C6 cycloalkyl, and optionally substituted C1-C6 alkoxyl;
E is an optionally substituted aryl, optionally substituted heteroaryl, or optionally substituted 3- to 8 membered heterocyclic;
Y is hydrogen, optionally substituted C1-C6 alkyl, optionally substituted -C1-C6 alkoxy, or optionally substituted C3-C6 cycloalkyl;
G is an optionally substituted heteroaryl; optionally substituted aryl; optionally substituted heteroaryl-C1-C3-alkyl; or optionally substituted aryl-C1-C3-alkyl; and
N is 1, 2 or 3.